stars 1 stars 2 stars 3

Sedatelec, is a public limited companies (SAS) with a capital of 160 000 euros specialized in the design and distribution of medical equipment. It exports about 80% of its production, in more than 40 countries, in Europe and the rest of the world. Sedatelec worked with Doctor Paul Nogier, the father of Auriculotherapy and developed the first sterile semi-permanent ear needle, the ASP®. It also created the first electronic devices and lasers for doctors carrying out this new medical technique. As a result of the development and diffusion of Auriculotherapy then Auriculomedicine, the second technique developed by Dr Nogier, the activity of Sedatelec has developed and is continuing to extend throughout the world. Thereafter, it expanded its market to acupuncture and progressively to other forms of alternative medicine (Reflexology, Photonotherapy®, Etiomedicine, etc). Sedatelec is dedicated to complying with the most up-to-date regulations governing health products, and always takes the greatest care when it comes to product safety and quality. The Sedatelec Quality Management System is certified by TÜV SÜD (CE 0123)

View Top Employees from SEDATELEC

SEDATELEC Questions

The SEDATELEC annual revenue was $3 million in 2024.

10 people are employed at SEDATELEC.

SEDATELEC is based in Irigny, Auvergne Rhone Alpes.

The NAICS codes for SEDATELEC are [621399, 6213, 62, 62139, 621].

The SIC codes for SEDATELEC are [80, 804].

How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users